Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 82

Results For "2023"

1101 News Found

Indoco receives EIR for its Plant I manufacturing facility in Goa
Drug Approval | May 04, 2023

Indoco receives EIR for its Plant I manufacturing facility in Goa

Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.


Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer
People | May 04, 2023

Astec LifeSciences appoints K. Suryanarayan as Chief Financial Officer

He has over two decades of leadership experience as an innovative strategic planner in finance diligence


Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
News | May 03, 2023

Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr

The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year


IMCD Colombia acquires pharma API distributor Allianz
Supply Chain | May 03, 2023

IMCD Colombia acquires pharma API distributor Allianz

Allianz is ISO 9001:2015 certified and INVIMA certified for storage, sampling, dispensation, and distribution of APIs to the Colombian market


Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData
News | May 02, 2023

Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis: GlobalData

Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis


Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil
News | May 01, 2023

Mitsui Chemicals ‘Super-Bond’ dental adhesive to launch in Brazil

Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder


IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr
News | May 01, 2023

IOL Chemicals and Pharmaceuticals reports Q4 FY23 PAT at Rs. 65 Cr

Net profit for FY23 at Rs. 140 crore as compared to Rs. 166 crore in FY22


Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr
News | April 30, 2023

Aarti Drugs reports Q4 FY23 PAT at Rs.56.02 Cr

Specialty Chemicals grew 38% YoY for FY23


Atul appoints Rangaswamy Iyer as Independent Director
People | April 29, 2023

Atul appoints Rangaswamy Iyer as Independent Director

The appointment is effective from May 01, 2023 for five years


Evonik starts construction of new U.S. facility for pharmaceutical lipids
News | April 29, 2023

Evonik starts construction of new U.S. facility for pharmaceutical lipids

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness